skip to primary navigationskip to content
 

Addenbrooke's takes over the GeneAdviser ordering platform for genetic testing

last modified Jun 21, 2017 03:42 PM
GeneAdviser's platform to live on as in-house NHS tool

ideaSpace alumni, GeneAdviser, a start-up with the aim of making genomic medicine more accessible is handing over its ordering platform for use within the NHS. The Cambridge start up will be closing its doors after the handover.

“Our goal has always been to make genomic medicine more accessible. We are delighted that this transition will mean that doctors will have long term access to the platform for use within the NHS.” said Dr Jelena Aleksic, GeneAdviser’s CEO.

The move follows the decision not to seek further investment for GeneAdviser, despite the platform being fully operational and having more than ten partner laboratories offering tests worldwide. “While as a unique product it is not enough to maintain a company, the platform is perfect as part of the NHS, making sure it remains accessible for doctors to use”, added Dr Aleksic. “This will also ensure the future of the platform independently of GeneAdviser”.

The platform will be maintained by the Cambridge University Hospitals NHS Regional Genetics Centre at Addenbrooke’s hospital. “The long-term goal is to get the platform adopted for genetic test ordering across the NHS,” said laboratory director Dr Steve Abbs. “We believe that the GeneAdviser platform solves an important problem of genetic test access, and we are very pleased that it will become an in-house NHS tool.” 

“It was always important for us to work closely with the genetics community," said Dr Robert Stojnic, GeneAdviser’s CTO. “We believe that being maintained directly by the community is the best move for the future growth and sustainability of the platform." 

The platform will be handed over to Addenbrooke's in late June, and will continue to be available through www.geneadviser.com during the transition period. It will later become a part of the NHS N3 computing network. Accessibility is guaranteed for all users during the transition.

For interviews and more information, contact:

  • Jelena Aleksic, GeneAdviser, jelena@geneadviser.com, +44 (0)7793534121

 

Notes to editors

About GeneAdviser

http://www.geneadviser.com 

Genetics is advancing at a rapid pace, transforming research and revolutionising the way we diagnose and treat complex diseases such as heart disease and cancer. We are a team of scientists and developers specialised in genetics and bioinformatics, working to increase access to genomic medicine in the clinic. 

We have developed an ordering platform to make genomic medicine more accessible, partnering with a portfolio of private and public laboratories in the UK and overseas. Our flexible, powerful online ordering platform for genetic tests enables clinicians to find and order tests for all medical specialities.  

About Cambridge University Hospitals NHS Regional Genetics Centre

http://www.cuh.org.uk/clinical-genetics

Addenbrooke’s is a centre of excellence for medical genetics and rare cancer treatment. The Genetic Testing Laboratory is part of the East Anglian Medical Genetics Service. The genetics laboratories offer cytogenetic (chromosome) and molecular genetic (DNA) analysis.

The laboratories are located within purpose built facilities (built 2007), and are rapidly expanding with more than 60 staff consisting of clinical scientists, biomedical scientists, genetic technologists, healthcare scientist trainees at different levels and administration staff.

 

 

RSS Feed Latest news

GeoSpock Lands £10 Million in Additional Funding 

Jan 09, 2019

ideaSpace alumni and extreme data specialists, GeoSpock, have secured an extra  £10 million in funding. The latest round was led by Cambridge Innovation Capital (CIC) jointly with Parkwalk Advisors and Japanese firms Global Brain and 31Ventures. Japanese data tech company KDDI Supership joined as a strategic investor. Investment was also secured from existing investor, Jonathan Milner.

A Breath Test Could Detect Early Cancer Signs

Jan 06, 2019

CRUK and ideaSpace City members, Owlstone Medical, have launched a new trial to discover whether it's possible to detect early stage cancer symptoms from a person's breath.

Petagene secure $2.1 Million in Funding 

Jan 03, 2019

2019 is off to a great start for the Petagene team who have been awarded $2.1 million in additional funding. The latest round was lead by U.S. venture firm Romulus Capital, with collaboration from other unnamed investors in London and Silicon Valley, bringing the total funding awarded to $3.2 million.

LESSONS FOR A FOUNDER: Your Fundraising Questions Answered

Dec 20, 2018

Are you going to be fundraising for your startup in 2019? The landscape of startup funding can seem bewildering. So we asked experienced fundraising coach, Jonathan Leinmuller, to share his knowledge about how best to raise capital. Here’s what he had to say...

C1209 Selected as a Startup With High Potential for International Scale

Dec 14, 2018

ideaSpace City members C1209 have been selected by Virgin as a startup with high potential for international scale, as part of the Virgin StartUp StepUp programme. This follows on from a recent feature in British Vogue which named C1209's Franklin bag as 'One of the Best Office Bags For Women'. 

View all news